Clinical Trial Update: JAB-2485 Activity in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Jacobio's JAB-2485 is being studied in Phase 1/2 for adults with advanced solid tumors, including breast cancer subtypes and small cell lung cancer, and the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Small Cell Lung Cancer

Drugs mentioned

• JAB-2485

Snippet

Sponsor: Jacobio Pharmaceuticals Co., Ltd. | Conditions: Solid Tumors, ER+ Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING